The brain heme oxygenase/biliverdin reductase system as a target in drug research and development

References

• Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem. 1969;244:6388–6394. Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.
   PubMed Web of Science ®Google Scholar
• Pimstone NR, Tenhunen R, Seitz PT, et al. The enzymatic degradation of hemoglobin to bile pigments by macrophages. J Exp Med. 1971;133:1264–1281.
   PubMed Web of Science ®Google Scholar
• Tenhunen R. Method for microassay of microsomal heme oxygenase activity. Anal Biochem. 1972;45:600–607.
   PubMed Web of Science ®Google Scholar
• Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem. 1986;261:411–419.
   PubMed Web of Science ®Google Scholar
• Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517–554.
   PubMed Web of Science ®Google Scholar
• Mancuso C. Biliverdin reductase as a target in drug research and development: facts and hypotheses. Free Radic Biol Med. 2021;172:521–529.
   PubMed Web of Science ®Google Scholar
• Mancuso C. Bilirubin and brain: a pharmacological approach. Neuropharmacology. 2017;118:113–123.
   PubMed Web of Science ®Google Scholar
• Schipper HM, Song W, Tavitian A, et al. The sinister face of heme oxygenase-1 in brain aging and disease. Prog Neurobiol. 2019;172:40–70.
   PubMed Web of Science ®Google Scholar
• Mancuso C, Barone E. The heme oxygenase/biliverdin reductase pathway in drug research and development. Curr Drug Metab. 2009;10:579–594.
   PubMed Web of Science ®Google Scholar
• Mancuso C, Navarra P, Preziosi P. Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. J Neurochem. 2010;113:563–575.
   PubMed Web of Science ®Google Scholar
• Consoli V, Sorrenti V, Grosso S, et al. Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions. Biomolecules. 2021;11:589.
   PubMed Web of Science ®Google Scholar
• Siracusa R, Schaufler A, Calabrese V, et al. Carbon monoxide: from poison to clinical trials. Trends Pharmacol Sci. 2021;42:329–339.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Wang J, Rousseau DL, et al. Heme-heme oxygenase complex. Structure of the catalytic site and its implication for oxygen activation. J Biol Chem. 1994;269:1010–1014.
   PubMed Web of Science ®Google Scholar
• Wilks A, Torpey J, Ortiz de Montellano PR. Heme oxygenase (HO-1). Evidence for electrophilic oxygen addition to the porphyrin ring in the formation of alpha-meso-hydroxyheme. J Biol Chem. 1994;269:29553–29556.
   PubMed Web of Science ®Google Scholar
• Vreman HJ, Ekstrand BC, Stevenson DK. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res. 1993;33:195–200.
   PubMed Web of Science ®Google Scholar
• Yang G, Nguyen X, Ou J, et al. Unique effects of zinc protoporphyrin on HO-1 induction and apoptosis. Blood. 2001;97:1306–1313.
   PubMed Web of Science ®Google Scholar
• Maines MD, Cohn J. Bile pigment formation by skin heme oxygenase: studies on the response of the enzyme to heme compounds and tissue injury. J Exp Med. 1977;145:1054–1059.
   PubMed Web of Science ®Google Scholar
• Wong RJ, Vreman HJ, Schulz S, et al. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins. J Perinatol. 2011;31 Suppl 1:S35–41.
   PubMed Web of Science ®Google Scholar
• Maines MD, Panahian N. The heme oxygenase system and cellular defense mechanisms. Do HO-1 and HO-2 have different functions? Adv Exp Med Biol. 2001;502:249–272.
   PubMed Web of Science ®Google Scholar
• Maines MD. The heme oxygenase system: update 2005. Antioxid Redox Signal. 2005;7:1761–1766.
   PubMed Web of Science ®Google Scholar
• Grochot-Przeczek A, Dulak J, Jozkowicz A. Haem oxygenase-1: non-canonical roles in physiology and pathology. Clin Sci (Lond). 2012;122:93–103.
   PubMed Web of Science ®Google Scholar
• Mancuso C. Heme oxygenase and its products in the nervous system. Antioxid Redox Signal. 2004;6:878–887.
   PubMed Web of Science ®Google Scholar
• Dwyer BE, Nishimura RN, Lu SY. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res Mol Brain Res. 1995;30:37–47.
   PubMedGoogle Scholar
• Ewing JF, Weber CM, Maines MD. Biliverdin reductase is heat resistant and coexpressed with constitutive and heat shock forms of heme oxygenase in brain. J Neurochem. 1993;61:1015–1023.
   PubMed Web of Science ®Google Scholar
• Ewing JF, Maines MD. Immunohistochemical localization of biliverdin reductase in rat brain: age related expression of protein and transcript. Brain Res. 1995;672:29–41.
   PubMed Web of Science ®Google Scholar
• Medina MV, Sapochnik D, Garcia Solá M, et al. Regulation of the expression of heme oxygenase-1: signal transduction, gene promoter activation, and beyond. Antioxid Redox Signal. 2020;32:1033–1044.
   PubMed Web of Science ®Google Scholar
• Alam J, Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol. 2007;36:166–174.
   PubMed Web of Science ®Google Scholar
• Kahroba H, Ramezani B, Maadi H, et al. The role of Nrf2 in neural stem/progenitors cells: from maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease. Ageing Res Rev. 2021;65:101211.
   PubMed Web of Science ®Google Scholar
• Gureev AP, Popov VN, Starkov AA. Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation. Exp Neurol. 2020;328:113285.
   PubMed Web of Science ®Google Scholar
• Catino S, Paciello F, Miceli F, et al. Ferulic acid regulates the nrf2/heme oxygenase-1 system and counteracts trimethyltin-induced neuronal damage in the human neuroblastoma cell line SH-SY5Y. Front Pharmacol. 2016;6:305.
   PubMed Web of Science ®Google Scholar
• Sun J, Hoshino H, Takaku K, et al. Hemoprotein bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 2002;21:5216–5224.
   PubMed Web of Science ®Google Scholar
• He F, Ru X, Wen T. NRF2, a transcription factor for stress response and beyond. Int J Mol Sci. 2020;21:4777.
   PubMed Web of Science ®Google Scholar
• Maines MD. New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology (Bethesda). 2005;20:382–389.
   PubMed Web of Science ®Google Scholar
• Palozza P, Serini S, Currò D, et al. beta-Carotene and cigarette smoke condensate regulate heme oxygenase-1 and its repressor factor bach1: relationship with cell growth. Antioxid Redox Signal. 2006;8:1069–1080.
   PubMed Web of Science ®Google Scholar
• Shibahara S. The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism. Tohoku J Exp Med. 2003;200:167–186.
   PubMed Web of Science ®Google Scholar
• Mancuso C, Preziosi P, Grossman AB, et al. The role of carbon monoxide in the regulation of neuroendocrine function. Neuroimmunomodulation. 1997;4:225–229.
   PubMed Web of Science ®Google Scholar
• Igarashi K, Sun J. The heme-Bach1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid Redox Signal. 2006;8:107–118.
   PubMed Web of Science ®Google Scholar
• Kitamuro T, Takahashi K, Ogawa K, et al. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem. 2003;278:9125–9133.
   PubMed Web of Science ®Google Scholar
• Udono-Fujimori R, Takahashi K, Takeda K, et al. Expression of heme oxygenase-1 is repressed by interferon-gamma and induced by hypoxia in human retinal pigment epithelial cells. Eur J Biochem. 2004;271:3076–3084.
   PubMedGoogle Scholar
• Oyake T, Itoh K, Motohashi H, et al. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with mafk and regulate transcription through the NF-E2 site. Mol Cell Biol. 1996;16:6083–6095.
   PubMed Web of Science ®Google Scholar
• Di Domenico F, Pupo G, Mancuso C, et al. Bach1 overexpression in down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer’s disease. J Alzheimers Dis. 2015;44:1107–1120.
   PubMed Web of Science ®Google Scholar
• Salinas M, Wang J, Rosa de Sagarra M, et al. Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo. FEBS Lett. 2004;578:90–94.
   PubMed Web of Science ®Google Scholar
• Barone E, Di Domenico F, Sultana R, et al. Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med. 2012;52:3118–3127.
   Web of Science ®Google Scholar
• Raju VS, Wk M Jr, Maines MD. Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: characterization of a functional glucocorticoid response element. Biochim Biophys Acta. 1997;1351:89–104.
   PubMedGoogle Scholar
• Li X, Clark JD. Spinal cord nitric oxide synthase and heme oxygenase limit morphine induced analgesia. Brain Res Mol Brain Res. 2001;95:96–102.
   PubMedGoogle Scholar
• Liu L, Dumbrepatil AB, Fleischhacker AS, et al. Heme oxygenase-2 is post-translationally regulated by heme occupancy in the catalytic site. J Biol Chem. 2020;295:17227–17240.
   PubMed Web of Science ®Google Scholar
• Boehning D, Sedaghat L, Sedlak TW, et al. Heme oxygenase-2 is activated by calcium-calmodulin. J Biol Chem. 2004;279:1457–1461.
   Web of Science ®Google Scholar
• Coburn RF. Endogenous carbon monoxide production. N Engl J Med. 1970;282:207–209.
   PubMed Web of Science ®Google Scholar
• Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev. 2005;57:585–630.
   PubMed Web of Science ®Google Scholar
• Verma A, Hirsch DJ, Glatt CE, et al. Carbon monoxide: a putative neural messenger. Science. 1993;259:381–384.
   PubMed Web of Science ®Google Scholar
• Steiner AA, Branco LG. Carbon monoxide is the heme oxygenase product with a pyretic action: evidence for a cGMP signaling pathway. Am J Physiol Regul Integr Comp Physiol. 2001;280:R448–57.
   PubMed Web of Science ®Google Scholar
• Lamar CA, Mahesh VB, Brann DW. Regulation of gonadotrophin-releasing hormone (GnRH) secretion by heme molecules: a regulatory role for carbon monoxide? Endocrinology. 1996;137:790–793.
   PubMed Web of Science ®Google Scholar
• Ingi T, Ronnett GV. Direct demonstration of a physiological role for carbon monoxide in olfactory receptor neurons. J Neurosci. 1995;15:8214–8222.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nozaki-Taguchi N. Zinc protoporphyrin IX, an inhibitor of the enzyme that produces carbon monoxide, blocks spinal nociceptive transmission evoked by formalin injection in the rat. Brain Res. 1995;704:256–262.
   PubMed Web of Science ®Google Scholar
• Fin C, Schmitz PK, Da Silva RC, et al. Intrahippocampal, but not intra-amygdala, infusion of an inhibitor of heme oxygenase causes retrograde amnesia in the rat. Eur J Pharmacol. 1994;271:227–229.
   PubMed Web of Science ®Google Scholar
• Glaum SR, Miller RJ. Zinc protoporphyrin-IX blocks the effects of metabotropic glutamate receptor activation in the rat nucleus tractus solitarii. Mol Pharmacol. 1993;43:965–969.
   PubMed Web of Science ®Google Scholar
• Faizan M, Muhammad N, Niazi KUK, et al. CO-releasing materials: an emphasis on therapeutic implications, as release and subsequent cytotoxicity are the part of therapy. Materials (Basel). 2019;12(10):1643.
   Web of Science ®Google Scholar
• Clark JE, Naughton P, Shurey S, et al. Cardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule. Circ Res. 2003;93(2):e2–8.
   PubMed Web of Science ®Google Scholar
• Jung E, Koh S-H, Yoo M, et al. Regenerative potential of carbon monoxide in adult neural circuits of the central nervous system. Int J Mol Sci. 2020;21(7):2273.
   Web of Science ®Google Scholar
• Johnson RA, Johnson FK. The effects of carbon monoxide as a neurotransmitter. Curr Opin Neurol. 2000;13:709–713.
   PubMed Web of Science ®Google Scholar
• Mhillaj E, Papi M, Paciello F, et al. Celecoxib exerts neuroprotective effects in β-amyloid-treated sh-sy5y cells through the regulation of heme oxygenase-1: novel insights for an old drug. Front Cell Dev Biol. 2020;8:561179.
   PubMed Web of Science ®Google Scholar
• Dreyer-Andersen N, Almeida AS, Jensen P, et al. Intermittent, low dose carbon monoxide exposure enhances survival and dopaminergic differentiation of human neural stem cells. PLoS One. 2018;13(1):e0191207.
   PubMed Web of Science ®Google Scholar
• Vieira HLA, Queiroga CSF, Alves PM. Pre-conditioning induced by carbon monoxide provides neuronal protection against apoptosis. J Neurochem. 2008;107(2):585–630.
   Web of Science ®Google Scholar
• Lin -C-C, Yang -C-C, Hsiao L-D, et al. Heme oxygenase-1 induction by carbon monoxide releasing molecule-3 suppresses interleukin-1β-mediated neuroinflammation. Front Mol Neurosci. 2017;10:387.
   PubMed Web of Science ®Google Scholar
• Schallner N, Romão CC, Biermann J, et al. Carbon monoxide abrogates ischemic insult to neuronal cells via the soluble guanylate cyclase-cGMP pathway. PLoS One. 2013;8:e60672.
   PubMed Web of Science ®Google Scholar
• Jaggar JH, Leffler CW, Cheranov SY, et al. Carbon monoxide dilates cerebral arterioles by enhancing the coupling of Ca 2+ sparks to Ca 2+ -activated K + channels. Circ Res. 2002;91(7):610–617.
   PubMed Web of Science ®Google Scholar
• Choi YK, Park JH, Baek YY, et al. Carbon monoxide stimulates astrocytic mitochondrial biogenesis via L-type Ca2+ channel-mediated PGC-1α/ERRα activation. Biochem Biophys Res Commun. 2016;479:297–304.
   PubMed Web of Science ®Google Scholar
• Riego G, Redondo A, Leánez S, et al. Mechanism implicated in the anti-allodynic and anti-hyperalgesic effects induced by the activation of heme oxygenase 1/carbon monoxide signaling pathway in the central nervous system of mice with neuropathic pain. Biochem Pharmacol. 2018;148:52–63.
   PubMed Web of Science ®Google Scholar
• Basuroy S, Tcheranova D, Bhattacharya S, et al. Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-α-induced apoptosis. Am J Physiol Cell Physiol. 2011;300:C256–65.
   PubMed Web of Science ®Google Scholar
• Ryter SW. Heme oxygenase-1/carbon monoxide as modulators of autophagy and inflammation. Arch Biochem Biophys. 2019;678:108186.
   PubMed Web of Science ®Google Scholar
• Queiroga CS, Vercelli A, Vieira HL. Carbon monoxide and the CNS: challenges and achievements. Br J Pharmacol. 2015;172:1533–1545.
   PubMed Web of Science ®Google Scholar
• Zhang J, Piantadosi CA. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest. 1992;90:1193–1199.
   PubMed Web of Science ®Google Scholar
• Mancuso C, Tringali G, Grossman A, et al. The generation of nitric oxide and carbon monoxide produces opposite effects on the release of immunoreactive interleukin-1beta from the rat hypothalamus in vitro: evidence for the involvement of different signaling pathways. Endocrinology. 1998;139:1031–1037.
   PubMed Web of Science ®Google Scholar
• Mancuso C, Pistritto G, Tringali G, et al. Evidence that carbon monoxide stimulates prostaglandin endoperoxide synthase activity in rat hypothalamic explants and in primary cultures of rat hypothalamic astrocytes. Brain Res Mol Brain Res. 1997;45:294–300.
   PubMedGoogle Scholar
• Hopper CP, Zambrana PN, Goebel U, et al. A brief history of carbon monoxide and its therapeutic origins. Nitric Oxide. 2021;111-112:45–63.
   PubMed Web of Science ®Google Scholar
• Csongradi E, Juncos LA, Drummond HA, et al. Role of carbon monoxide in kidney function: is a little carbon monoxide good for the kidney? Curr Pharm Biotechnol. 2012;13:819–826.
   PubMed Web of Science ®Google Scholar
• Li J, Peng L, Bai W, et al. biliverdin protects against cerebral ischemia/reperfusion injury by regulating the miR-27a-3p/Rgs1 Axis. Neuropsychiatr Dis Treat. 2021;17:1165–1181.
   PubMed Web of Science ®Google Scholar
• Zou ZY, Liu J, Chang C, et al. Biliverdin administration regulates the microRNA-mRNA expressional network associated with neuroprotection in cerebral ischemia reperfusion injury in rats. Int J Mol Med. 2019;43:1356–1372.
   PubMed Web of Science ®Google Scholar
• Bisht K, Wegiel B, Tampe J, et al. Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling. Biochem Biophys Res Commun. 2014;449:94–99.
   PubMed Web of Science ®Google Scholar
• Tang LM, Wang YP, Wang K, et al. Exogenous biliverdin ameliorates ischemia-reperfusion injury in small-for-size rat liver grafts. Transplant Proc. 2007;39:1338–1344.
   PubMed Web of Science ®Google Scholar
• Nakao A, Neto JS, Kanno S, et al. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant. 2005;5:282–291.
   PubMed Web of Science ®Google Scholar
• Mölzer C, Wallner M, Kern C, et al. Characteristics of the heme catabolic pathway in mild unconjugated hyperbilirubinemia and their associations with inflammation and disease prevention. Sci Rep. 2017;7:755.
   PubMed Web of Science ®Google Scholar
• Schwertner HA, Vítek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008;198:1–11.
   PubMed Web of Science ®Google Scholar
• Tsiftsoglou AS, Tsamadou AI, Papadopoulou LC. Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther. 2006;111:327–345.
   PubMed Web of Science ®Google Scholar
• DeGregorio-Rocasolano N, Martí-Sistac O, Gasull T. Deciphering the iron side of stroke: neurodegeneration at the crossroads between iron dyshomeostasis, excitotoxicity, and ferroptosis. Front Neurosci. 2019;13:85.
   PubMed Web of Science ®Google Scholar
• Chiueh CC. Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr Neurol. 2001;25:138–147.
   PubMed Web of Science ®Google Scholar
• Song W, Cressatti M, Zukor H, et al. Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment. Neurobiol Aging. 2017;58:163–179.
   PubMed Web of Science ®Google Scholar
• Hascalovici JR, Song W, Liberman A, et al. Neural HO-1/sterol interactions in vivo: implications for Alzheimer’s disease. Neuroscience. 2014;280:40–49.
   PubMed Web of Science ®Google Scholar
• Gáll T, Balla G, Balla JH. Heme oxygenase, and endoplasmic reticulum stress-a new insight into the pathophysiology of vascular diseases. Int J Mol Sci. 2019;20:3675.
   Web of Science ®Google Scholar
• Ono S, Zhang ZD, Marton LS, et al. Heme oxygenase-1 and ferritin are increased in cerebral arteries after subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab. 2000;20:1066–1076.
   PubMed Web of Science ®Google Scholar
• Panahian N, Yoshiura M, Maines MD. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem. 1999;72:1187–1203.
   PubMed Web of Science ®Google Scholar
• Chakrabarty A, Emerson MR, LeVine SM. Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis. Mult Scler. 2003;9:372–381.
   PubMed Web of Science ®Google Scholar
• Gonzales S, Erario MA, Tomaro ML. Heme oxygenase-1 induction and dependent increase in ferritin. A protective antioxidant stratagem in hemin-treated rat brain. Dev Neurosci. 2002;24:161–168.
   PubMed Web of Science ®Google Scholar
• Vanderah TW, Pappano AJ. Cholinoceptor-activating & cholinesterase-inhibiting drugs. In: Katzung BG, Vanderah TW, editors. Basic & clinical pharmacology. New York (NY): McGraw Hill; 2021. p. 111–128.
   Google Scholar
• Nakao A, Kaczorowski DJ, Zuckerbraun BS, et al. Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction. Biochem Biophys Res Commun. 2008;367:674–679.
   PubMed Web of Science ®Google Scholar
• Ma KG, Qian YH. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer’s disease. Neuropeptides. 2019;73:96–106.
   PubMed Web of Science ®Google Scholar
• Navarro E, Gonzalez-Lafuente L, Pérez-Liébana I, et al. Heme-oxygenase i and pcg-1α regulate mitochondrial biogenesis via microglial activation of alpha7 nicotinic acetylcholine receptors using PNU282987. Antioxid Redox Signal. 2017;27:93–105.
   PubMed Web of Science ®Google Scholar
• Navarro E, Buendia I, Parada E, et al. Alpha7 nicotinic receptor activation protects against oxidative stress via heme-oxygenase I induction. Biochem Pharmacol. 2015;97:473–481.
   PubMed Web of Science ®Google Scholar
• Foucault-Fruchard L, Tronel C, Bodard S, et al. Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington’s disease and involvement of heme oxygenase-1. Neural Regen Res. 2018;13:737–741.
   PubMed Web of Science ®Google Scholar
• Biaggioni I. Adrenoceptor agonists & sympathomimetic drugs. In: Katzung BG, Vanderah TW, editors. Basic & Clinical Pharmacology. New York (NY): McGraw Hill; 2021. p. 142–160.
   Google Scholar
• Khorchid A, Fragoso G, Shore G, et al. Catecholamine-induced oligodendrocyte cell death in culture is developmentally regulated and involves free radical generation and differential activation of caspase-3. Glia. 2002;40:283–299.
   PubMed Web of Science ®Google Scholar
• Schipper HM, Bernier L, Mehindate K, et al. Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore. J Neurochem. 1999;72:1802–1811.
   PubMed Web of Science ®Google Scholar
• Huang YN, Wu CH, Lin TC, et al. Methamphetamine induces heme oxygenase-1 expression in cortical neurons and glia to prevent its toxicity. Toxicol Appl Pharmacol. 2009;240:315–326.
   PubMed Web of Science ®Google Scholar
• Trevor AJ. Sedative-hypnotic drugs. In: Katzung BG, Vanderah TW, editors. Basic & clinical pharmacology. New York (NY): McGraw Hill; 2021. p. 395–409.
   Google Scholar
• Carvalho-Costa PG, Branco LG, Leite-Panissi CR. Activation of locus coeruleus heme oxygenase-carbon monoxide pathway promoted an anxiolytic-like effect in rats. Braz J Med Biol Res. 2016;49:e5135.
   PubMed Web of Science ®Google Scholar
• Rogawski MA. Antiseizure drugs. In: Katzung BG, Vanderah TW, editors. Basic & clinical pharmacology. New York (NY): McGraw Hill; 2021. p. 422–455.
   Google Scholar
• Park CW, Ahn JH, Lee TK, et al. Post-treatment with oxcarbazepine confers potent neuroprotection against transient global cerebral ischemic injury by activating Nrf2 defense pathway. Biomed Pharmacother. 2020;124:109850.
   PubMed Web of Science ®Google Scholar
• Liao G, Li R, Chen X, et al. Sodium valproate prevents radiation-induced injury in hippocampal neurons via activation of the Nrf2/HO-1 pathway. Neuroscience. 2016;331:40–51.
   PubMed Web of Science ®Google Scholar
• DeBattista C. Antidepressant agents. In: Katzung BG, Vanderah TW, editors. Basic & clinical pharmacology. New York (NY): McGraw Hill; 2021. p. 550–572.
   Google Scholar
• Omar NN, Tash RF. Fluoxetine coupled with zinc in a chronic mild stress model of depression: providing a reservoir for optimum zinc signaling and neuronal remodeling. Pharmacol Biochem Behav. 2017;160:30–38.
   PubMed Web of Science ®Google Scholar
• Engel DF, de Oliveira J, Lieberknecht V, et al. Duloxetine protects human neuroblastoma cells from oxidative stress-induced cell death through Akt/Nrf-2/HO-1 pathway. Neurochem Res. 2018;43:387–396.
   PubMed Web of Science ®Google Scholar
• Chen Z, Xu H, Haimano S, et al. Quetiapine and venlafaxine synergically regulate heme oxygenase-2 protein expression in the hippocampus of stressed rats. Neurosci Lett. 2005;389:173–177.
   PubMed Web of Science ®Google Scholar
• Tran NQV, Nguyen AN, Takabe K, et al. Pre-treatment with amitriptyline causes epigenetic up-regulation of neuroprotection-associated genes and has anti-apoptotic effects in mouse neuronal cells. Neurotoxicol Teratol. 2017;62:1–12.
   PubMed Web of Science ®Google Scholar
• Lin HY, Yeh WL, Huang BR, et al. Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons. PLoS One. 2012;7:e50138.
   PubMed Web of Science ®Google Scholar
• De Battista C. Antipsychotic agents & lithium. In: Katzung BG, Vanderah TW, editors. Basic & clinical pharmacology. New York (NY): McGraw Hill; 2021. p. 529–549.
   Google Scholar
• Terada K, Murata A, Toki E, et al. Atypical antipsychotic drug ziprasidone protects against rotenone-induced neurotoxicity: an in vitro study. Molecules. 2020;25:4206.
   Web of Science ®Google Scholar
• Lee YS, Park SY, Heo HJ, et al. Multitarget-directed cotreatment with cilostazol and aripiprazole for augmented neuroprotection against oxidative stress-induced toxicity in HT22 mouse hippocampal cells. Eur J Pharmacol. 2019;857:172454.
   PubMed Web of Science ®Google Scholar
• Schumacher MA, Basbaum AI, Naidu RK. Opioid agonists & antagonists. In: Katzung BG, Vanderah TW, editors. Basic & Clinical Pharmacology. New York (NY): McGraw Hill; 2021. p. 573–595.
   Google Scholar
• Liang D, Li X, Lighthall G, et al. Heme oxygenase type 2 modulates behavioral and molecular changes during chronic exposure to morphine. Neuroscience. 2003;121:999–1005.
   PubMed Web of Science ®Google Scholar
• Li X, Angst MS, Clark JD. A murine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res. 2001;86:56–62.
   PubMedGoogle Scholar
• Rabbani M, Hajhashemi V, Mesripour A. Increase in brain corticosterone concentration and recognition memory impairment following morphine withdrawal in mice. Stress. 2009;12:451–456.
   PubMedGoogle Scholar
• Núñez C, Földes A, Pérez-Flores D, et al. Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal. Endocrinology. 2009;150:3118–3127.
   PubMed Web of Science ®Google Scholar
• Castany S, Carcolé M, Leánez S, et al. the induction of heme oxygenase 1 decreases painful diabetic neuropathy and enhances the antinociceptive effects of morphine in diabetic mice. PLoS One. 2016;11:e0146427.
   PubMed Web of Science ®Google Scholar
• Castany S, Carcolé M, Leánez S, et al. The antinociceptive effects of a δ-opioid receptor agonist in mice with painful diabetic neuropathy: involvement of heme oxygenase 1. Neurosci Lett. 2016;614:49–54.
   PubMed Web of Science ®Google Scholar
• de Ávila Ma P, Giusti-Paiva A, de Oliveira Nascimento C G. The peripheral antinociceptive effect induced by the heme oxygenase/carbon monoxide pathway is associated with ATP-sensitive K+ channels. Eur J Pharmacol. 2014;726:41–48.
   PubMed Web of Science ®Google Scholar
• Abdel Aziz MT, Atta HM, Samer H, et al. Heme oxygenase effect on mesenchymal stem cells action on experimental Alzheimer’s disease. EXCLI J. 2013;12:778–792.
   PubMed Web of Science ®Google Scholar
• Bhardwaj M, Deshmukh R, Kaundal M, et al. Pharmacological induction of hemeoxygenase-1 activity attenuates intracerebroventricular streptozotocin induced neurocognitive deficit and oxidative stress in rats. Eur J Pharmacol. 2016;772:43–50.
   PubMed Web of Science ®Google Scholar
• Howlett D, Cutler P, Heales S, et al. Hemin and related porphyrins inhibit beta-amyloid aggregation. FEBS Lett. 1997;417:249–251.
   PubMed Web of Science ®Google Scholar
• Delmastro-Greenwood MM, Tse HM, Piganelli JD. Effects of metalloporphyrins on reducing inflammation and autoimmunity. Antioxid Redox Signal. 2014;20:2465–2477.
   PubMed Web of Science ®Google Scholar
• Sheng H, Chaparro RE, Sasaki T, et al. Metalloporphyrins as therapeutic catalytic oxidoreductants in central nervous system disorders. Antioxid Redox Signal. 2014;20:2437–2464.
   PubMed Web of Science ®Google Scholar
• Salerno L, Floresta G, Ciaffaglione V, et al. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application. Eur J Med Chem. 2019;167:439–453.
   PubMed Web of Science ®Google Scholar
• Vlahakis JZ, Kinobe RT, Bowers RJ, et al. Synthesis and evaluation of azalanstat analogues as heme oxygenase inhibitors. Bioorg Med Chem Lett. 2005;15:1457–1461.
   PubMedGoogle Scholar
• Fernández-Fierro A, Funes SC, Rios M, et al. Immune modulation by inhibitors of the HO system. Int J Mol Sci. 2020;22:294.
   Web of Science ®Google Scholar
• Mucha O, Podkalicka P, Mikulski M, et al. Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment. Arch Biochem Biophys. 2019;671:130–142.
   PubMed Web of Science ®Google Scholar
• Gupta A, Lacoste B, Pistell PJ, et al. Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer’s disease. J Neurochem. 2014;131(6):778–790.
   PubMed Web of Science ®Google Scholar
• Katzung BG. Introduction: the nature of drugs and drug development and regulation. In: Katzung BG, Vanderah TW, editors. Basic & clinical pharmacology. New York (NY): McGraw Hill; 2021. p. 1–20.
   Google Scholar
• Syapin PJ. Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br J Pharmacol. 2008;155(5):623–640.
   PubMed Web of Science ®Google Scholar
• Kaizaki A, Tanaka S, Ishige K, et al. The neuroprotective effect of heme oxygenase (HO) on oxidative stress in HO-1 siRNA-transfected HT22 cells. Brain Res. 2006;1108:39–44.
   PubMed Web of Science ®Google Scholar
• Fredenburgh LE, Perrella MA, Barragan-Bradford D, et al. A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS. JCI Insight. 2018;3:e124039.
   PubMed Web of Science ®Google Scholar
• Rosas IO, Goldberg HJ, Collard HR, et al. A phase II clinical trial of low-dose inhaled carbon monoxide in idiopathic pulmonary fibrosis. Chest. 2018;153:94–104.
   PubMed Web of Science ®Google Scholar
• Goodrich JA, Frisco DJ, Ryan SPP, et al. Intermittent low dose carbon monoxide inhalation does not influence glucose regulation in overweight adults: a randomized controlled crossover trial. Exp Physiol. 2020;105:460–467.
   PubMed Web of Science ®Google Scholar
• Schmidt WFJ, Hoffmeister T, Haupt S, et al. chronic exposure to low-dose carbon monoxide alters hemoglobin mass and V˙O2max. Med Sci Sports Exerc. 2020;52:1879–1887.
   PubMed Web of Science ®Google Scholar
• Ghanizada H, Arngrim N, Schytz HW, et al. Carbon monoxide inhalation induces headache but no migraine in patients with migraine without aura. Cephalalgia. 2018;38:1940–1949.
   PubMed Web of Science ®Google Scholar
• Abu Jawdeh BG, Woodle ES, Leino AD, et al. A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. Clin Transplant. 2018;32:e13155.
   Web of Science ®Google Scholar
• Misra H, Lickliter J, Kazo F, et al. PEGylated carboxyhemoglobin bovine (SANGUINATE): results of a phase I clinical trial. Artif Organs. 2014;38:702–707.
   PubMed Web of Science ®Google Scholar
• Coburn RF. The partial pressure of carbon monoxide in human tissues calculated using a parallel capillary-tissue cylinder model. J Appl Physiol. 2018;124:761–768. (1985).
   PubMed Web of Science ®Google Scholar
• Rennie J, Burman-Roy S, Murphy MS; Guideline Development Group. Neonatal jaundice: summary of NICE guidance. BMJ. 2010;340:c2409.
   PubMed Web of Science ®Google Scholar
• Suresh GK, Martin CL, Soll RF. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates. Cochrane Database Syst Rev. 2003;2. CD004207.
   Google Scholar
• Dennery PA. Metalloporphyrins for the treatment of neonatal jaundice. Curr Opin Pediatr. 2005;17:167–169.
   PubMed Web of Science ®Google Scholar
• Böni RE, Huch Böni RA, Galbraith RA, et al. Tin-mesoporphyrin inhibits heme oxygenase activity and heme-iron absorption in the intestine. Pharmacology. 1993;47:318–329.
   PubMed Web of Science ®Google Scholar
• Cooke RW. New approach to prevention of kernicterus. Lancet. 1999;353:1814–1815.
   PubMed Web of Science ®Google Scholar
• Fasae KD, Abolaji AO, Faloye TR, et al. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer’s disease: limitations, and current and future perspectives. J Trace Elem Med Biol. 2021;67:126779.
   PubMed Web of Science ®Google Scholar
• Ward RJ, Dexter DT, Martin-Bastida A, et al. Is chelation therapy a potential treatment for Parkinson’s disease? Int J Mol Sci. 2021;22:3338.
   PubMedGoogle Scholar
• Devos D, Moreau C, Devedjian JC, et al. Targeting chelatable iron as a therapeutic modality in Parkinson’s disease. Antioxid Redox Signal. 2014;21:195–210.
   PubMed Web of Science ®Google Scholar
• Martin-Bastida A, Ward RJ, Newbould R, et al. Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease. Sci Rep. 2017;7:1398.
   PubMed Web of Science ®Google Scholar
• McLachlan DR C, Dalton AJ, Kruck TP, et al. Intramuscular desferrioxamine in patients with Alzheimer’s disease. Lancet. 1991;337:1304–1308.
   PubMed Web of Science ®Google Scholar